980 results
Thumbnail

D2.310 - Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis

Thumbnail

D2.311 - Real World Web Survey on the Burden of Urticaria

Thumbnail

D2.312 - Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis

Thumbnail

D2.313 - Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks

Thumbnail

D2.315 - Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases

Thumbnail

D2.316 - The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis

Thumbnail

D2.317 - The role of sirtuin 2 (SIRT2) in atopic dermatitis

Thumbnail

D2.318 - Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients

Thumbnail

D2.319 - Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry

Thumbnail

D2.322 - Quality of life of families with children suffering from chronic urticaria

Thumbnail

D2.323 - Higher neonatal urinary phthalate are associated with the development of infantile atopic dermatitis

Thumbnail

D2.324 - Psychological Burden Associated with Injectable HAE On-Demand Treatments: A Patient and Caregiver Interview Study

Thumbnail

D2.325 - Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Thumbnail

D2.326 - Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study

Thumbnail

D2.327 - Outcome of hematopoietic stem cells transplantation for inborn error of immunity in Vietnam

Thumbnail

D2.328 - Comparison of the frequency of viral infections in immunocompromised patients receiving immunoglobulin by different routes

Thumbnail

D2.329 - Impact of Berotralstat on Quality of Life among Patients with Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials

Thumbnail

D2.330 - Hereditary angioedema prophylaxis therapy: berotralstat and lanadelumab safety profile

Thumbnail

D2.331 - Lanadelumab safety and efficacy in patients aged ≥12 with hereditary angioedema (HAE) in China for long-term prophylaxis (LTP): An open-label, multicenter study

Thumbnail

D2.334 - Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: A 12-Month Retrospective Study at a Single Center in Colombia